References
- Stroup M, MacIlroy M Jr. Five examples of an antibody defining an antigen of high frequency in the Caucasian population (conference abstract). 23rd Annual Meeting of the American Association of Blood Banks, San Francisco, CA; 1970:86.
- Gellerman M, Stroup M. Unpublished observations, cited in Race RR, Sanger R. Blood groups in man. 6th ed., pp. 441-424 (Blackwell, Oxford 1975).
- Miyazaki T, Kwon KW, Yamamoto K, et al. A human monoclonal antibody to high frequency red cell antigen Jra. Vox Sang 1994;66:51–4.
- Nakajima H, Ito K. An example of anti-Jracausing hemolytic disease of the newborn and frequency of Jraantigen in the Japanese population. Vox Sang 1978;35:265–7.
- Okubo Y. Some rare blood group phenotypes in Japanese, Fy(a–), Di(b–) and Jr(a–) (in Japanese). Blood Programme 1978;1:279–84.
- Tritchler JE. An example of anti-Jra. Transfusion 1977;17: 177–8.
- Kendal AG. Clinical importance of the rare erythrocyte antibody anti-Jra. Transfusion 1976;16:646–7.
- Levene C, Sela R, Dvilansky A, Yermiahu T, Daniels G. The Jr(a–) phenotype and anti-Jrain two Beduin Arab women in Israel. Transfusion 1986;26:119–20.
- Vedo M, Reid ME. Anti-Jrain a Mexican American. Transfusion 1978;18:569.
- Yamaguchi H, Okubo Y, Seno T, et al. A rare phenotype blood Jr(a–) occurring in two successive generations of a Japanese family. Proc Jpn Acad 1976;52:521–3.
- Orrick LR, Golde SH. Jramediated hemolytic disease of the newborn infant. Am J Obstet Gynecol 1980;137:135–6.
- Toy P, Reid M, Lewis T, Ellisor S, Avoy DR. Does anti-Jracause hemolytic disease of the newborn? Vox Sang 1981;41:40–4.
- Bacon J, Sherrin D, Wright RG. Case report, anti-Jra(letter). Transfusion 1986;26:543–4.
- Bellver-Pradas J, Arriaga-Chafer F, Perales-Marin A, Maisques-Montesinos V, Serra-Serra V. Obstetric significance of anti-Jra. Am J Obstet Gynecol 2001;184:75–6.
- Ishihara Y, Miyata S, Chiba Y, Kawai T. Successful treatment of extremely severe fetal anemia due to anti-Jraalloimmunization. Fetal Diagn Ther 2006;21:269–71.
- Peyrard T, Pham BN, Arnaud L, et al. Obstetric significance of anti-Jra: study of twenty pregnancy outcomes showing three cases of severe hemolytic disease of the fetus and newborn (abstract). Transfusion 2008;48(Suppl):14A.
- Peyrard T, Pham BN, Arnaud L, et al. Fatal hemolytic disease of the fetus and newborn associated with anti-Jra. Transfusion 2008;48:1906–11.
- Arriaga F, Gomez I, Lineares MD, Gascon A, Carpio N, Perales A. Fatal hemolytic disease of the fetus and newborn possibly due to anti-Jra(letter). Transfusion 2009;49:813.
- Masumoto A, Masuyama H, Sumida Y, Segawa T, Hiramatsu Y. Successful management of anti-Jraalloimmunization in pregnancy: a case report. Gynecol Obstet Invest 2010;69:81–3.
- Kim H, Park M-J, Sung T-J, et al. Hemolytic disease of the newborn associated with anti-Jraalloimmunization in a twin pregnancy: the first case report in Korea. Korean J Lab Med 2010;30:511–15.
- Sasamoto N, Tomimatsu T, Nagamine K, et al. Fetal and neonatal anemia associated with anti-Jra: a case report showing a poorly hemolytic mechanism. J. Obstet Gynaecol Res 2011;37:1132–6.
- Verska JJ, Larson NL. Autologous transfusion in cardiac surgery: a case report of a patient with a rare antibody. Transfusion 1973;13:219–20.
- Yoshida H, Yurugi K, Ito K. A case of delayed hemolytic transfusion reaction due to anti-Jra. Jpn J Tranfus Med 1991; 34:528–30.
- Jowitt S, Powell H, Shwe KH, Love EM. Transfusion reaction due to anti-Jra. (abstract). Transfusion Med 1994;4(Suppl 1):49.
- Pisacka M, Prosicka M, Kralova M, et al. Six cases of anti-Jra antibody detected in one year: a probable relation with Gypsy ethnic minority from central Slovakia. (abstract). Vox Sang 2000;78(suppl):P146.
- Yuan S, Armour R, Reid A, et al. Case report: massive postpartum transfusion of Jr(a+) red cells in the presence of anti-Jra. Immunohematology 2005;21:97–101.
- Kwon MY, Su L, Arndt P, Garratty G, Blackall DP. Clinical significance of anti-Jra: report of two cases and review of the literature. Transfusion 2004;44:197–201.
- Hundric Haspl HH, Jurakovic Loncar JL, et al. The clinical significance of anti-Jra: mild or severe? (abstract). Vox Sang 2007;93(Suppl 1):208–9.
- Lewis M, Anstee DJ, Bird GWG, et al. Blood group terminology 1990. The ISBT Working Party on Terminology for Red Cell Surface Antigens. Vox Sang 1990;58:152–69.
- Zelinski T, Coghlan G, Liu XG, Reid ME. ABCG2 null alleles define the Jr(a–) blood group phenotype. Nat Genet 2012;44:131–2.
- Saison C, Helias V, Balif BA, et al. Null alleles of ABCG2encoding the breast cancer resistance protein define the new blood group system Junior. Nat Genet 2012;44:174–7.
- Hue-Roye K, Lomas-Francis C, Coghlan G, Zelinski T, Reid ME. The JR blood group system (ISBT 032): molecular characterization of three new alleles. Transfusion 2012 Oct 15. [Epub ahead of print].
- Hue-Roye K, Zelinski T, Cobaugh A, Lomas-Francis C, Miyazaki T, Reid ME. The JR blood group system: alleles that alter expression? (abstract). Transfusion 2013 Feb 25. [Epub ahead of print].
- Imai Y, Nakane M, Kage K, et al. C421A polymorphism in the human breast cancer resistance protein gene is associated with low expression of Q141K protein and low-level drug resistance. Mol Cancer Ther 2002;1:611–16.
- Kobayashi D, Ieiri I, Hirota T, et al. Functional assessment of ABCG2 (BCRP) gene polymorphisms to protein expression in human placenta. Drug Metab Dispos 2005;33:94–101.
- Bailey-Dell KJ, Hassel B, Doyle LA, Ross DD. Promoter characterization and genomic organization of the human breast cancer resistance protein (ATP-binding cassette transporter G2) gene. Biochim Biophys Acta 2001;1520:234–41.
- Klein I, Sarkadi B, Váradi A. An inventory of the human ABC proteins. Biochim Biophys Acta 1999;1461:237–62.
- Woodward OM, Köttgen A, Köttgen M. ABCG transporters and disease. FEBS J 2011;278:3215–25.
- Leimanis ML, Georges E. ABCG2 membrane transporter in mature human erythrocytes is exclusively homodimer. Biochem Biophys Res Commun 2007;354:345–50.
- Xu J, Liu Y, Yang Y, Bates S, Zhang JT. Characterization of oligomeric human half-ABC transporter ATP-binding cassette G2. J Biol Chem 2004;279:19781–9.
- Doyle LA, Yang W, Abruzzo LV, et al. A multidrug resistance transporter from human MCF-7 breast cancer cells. Proc Natl Acad Sci USA 1998;95:15665–70.
- Maliepaard M, Scheffer GL, Faneyte IF, et al. Subcellular localization and distribution of the breast cancer resistance protein transporter in normal human tissues. Cancer Res 2001;61:3458–64.
- Allikmets R, Schriml LM, Hutchinson A, Romano-Spica V, Dean M. A human placenta-specific ATP binding cassette gene (ABCP) on chromosome 4q22 that is involved in multidrug resistance. Cancer Res 1998;58:5337–9.
- Miyake K, Mickley L, Litman T, et al. Molecular cloning of cDNAs which are highly overexpressed in mitoxantrone-resistant cells: demonstration of homology to ABC transport genes. Cancer Res 1999;59:8–13.
- Woodward OM, Köttgen A, Coresh J, Boerwinkle E, Guggino WB, Köttgen M. Identification of urate transporter, ABCG2, with a common functional polymorphism causing gout. Proc Natl Acad Sci U S A 2009;106:10338–42.
- Wielinga P, Hooijberg JH, Gunnarsdottir S, et al. The human multidrug resistance protein MRP5 transports folates and can mediate cellular resistance against antifolates. Cancer Res 2005;65:4425–30.
- Krishnamurthy P, Xie T, Schuetz JD. The role of transporters in cellular heme and porphyrin homeostasis. Pharmacol Ther 2007;114:345–58.
- Tamura A, Masato W, Saito H, et al. Functional validation of the genetic polymorphisms of human ATP-binding cassette (ABC) transporter ABCG2: identification of alleles that are defective in porphyrin transport. Mol Pharmacol 2006;70:287–96.
- Huls M, Russel FG, Masereeuw R. The role of ATP binding cassette transporters in tissue defense and organ regeneration. J Pharmacol Exp Ther 2009;328:3–9.
- Kusuhara H, Sugiyama Y. Active efflux across the blood-brain barrier: role of the solute carrier family. NeuroRx 2005;2: 73–85.
- Dauchy S, Dutheil F, Weaver RJ, et al. ABC transporters, cytochromes P450 and their main transcription factors: expression at the human blood-brain barrier. J Neurochem 2008;107:1518–28.
- Borst P, Elferink O. Mammalian ABC transporters in health and disease. Annu Rev Biochem 2002;71:537–92.
- Doyle L, Ross DD. Multidrug resistance mediated by the breast cancer resistance protein BCRP (ABCG2). Oncogene 2003;22:7340–58.
- Natarajan K, Xie Y, Baer MR, Ross DD. Role of breast cancer resistance protein (BCRP/ABCG2) in cancer drug resistance. Biochem Pharmacol 2012;83:1084–103.
- Matsuo H, Takada T, Ichida K, et al. Common defects of ABCG2, a high-capacity urate transporter, cause gout: a function-based genetic analysis in a Japanese population. Sci Transl Med 2009;1:5ra11.
- Tiribelli M, Fabbro D, Franzoni A, Fanin R, Damante G, Damiani D. Q141K polymorphism of ABCG2 protein is associated with poor prognosis in adult acute myeloid leukemia treated with idarubicin-based chemotherapy. Haematologica 2012 Oct 12. [Epub ahead of print].
- Reid ME, Lomas-Francis C, Olsson ML. The blood group antigen factsbook. 3rd ed. San Diego, CA: Elsevier; 2012.
- Takeshita A, Watanabe H, Fijihara H, et al. Collaborative study of irregular erythrocyte antibodies in Japan: results from the Japanese study group of allo-immunity and antigen diversity in Asian populations. Transf Apher Sci 2010;43:3–8.
- Ogasawara K, Mazuda T. Characterization of Jraantibodies by monocyte phagocytosis assays and flow cytometry analysis (in Japanese). Acta Haematol Jpn 1990;53:1131–7.
- Garratty G, Arndt P, Nance S. The potential clinical significance of blood group alloantibodies to high frequency antigens (abstract). Blood 1997;10(Suppl 1):473a.
- Vaughan JI, Warwick R, Letsky E, Nicolini U, Rodeck CH, Fisk NM. Erythropoietic suppression in fetal anemia because of Kell alloimmunization. Am J Obstet Gynecol 1994;171:247–52.
- Arndt PA, Garratty G, Daniels G, et al. Late onset neonatal anaemia due to maternal anti-Ge: possible association with destruction of erythroid progenitors. Transfus Med 2005;15:125–32.
DOI: https://doi.org/10.21307/immunohematology-2019-126 | Journal eISSN: 1930-3955 | Journal ISSN: 0894-203X
Language: English
Page range: 63 - 68
Published on: Dec 1, 2019
Published by: American National Red Cross
In partnership with: Paradigm Publishing Services
Publication frequency: 4 times per year
Keywords:
Related subjects:
© 2019 L. Castilho, M.E. Reid, published by American National Red Cross
This work is licensed under the Creative Commons License.